Interní Med. 2003; 5(9): 434-436

Antifosfolipidový syndrom

MUDr. Antonín Hluší, doc. MUDr. Věra Krčová CSc
Hemato-onkologická klinika FN a LF UP v Olomouci

Keywords: antiphospholipid syndrome, lupus anticoagulant, anticardiolipin antibody, thrombosis.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hluší A, Krčová V. Antifosfolipidový syndrom. Interní Med. 2003;5(9):434-436.

Antifosfolipidový syndrom (APS) je získané autoimunitní onemocnění definované klinicky a laboratorně. Klinická diagnostická kritéria zahrnují žilní či arteriální trombózy, komplikace v těhotenství, trombocytopenii. Laboratorně musí být opakovaně prokázány antifosfolipidové protilátky - buď koagulačními testy (LA - lupus antikoagulans), nebo ELISA metodami (ACLA - antikardiolipinové protilátky). Výskyt antifosfolipidových protilátek může provázet řadu onemocnění (autoimunitní, malignity), nebo je primární. Klinická manifestace může být velmi pestrá v řadě medicínských oborů. Akutní průběh - katastrofický APS - je naštěstí vzácný.

Antiphospholipid antibody syndrome

Antiphospholipid antibody syndrome (APS) is an acquired autoimmune disorder charakte-rized by clinical and laboratory attributes. Clinical diagnostic criteria comprise venous or arterial thrombosis, pregnancy complications, thrombocytopenia. Laboratory testing must be repeated positive for antiphospholipid antibodies - either coagulation tests (LA - lupus anticoagulant) or ELISA methods (ACLA - anticardiolipin antibody). Many disorders (autoimmune, malignancies) can be accompanied by a presence of antiphospholipid antibodies. APS occurs in primary form with no associated illness. Clinical manifestation can be miscellaneous in different medical fields. Fulminant course - catastrophic APS appears to be rare.

Download citation

References

  1. Bauer KA. Hypercoagulable States. In: Hematology, Churchill-Livingstone London 2000: 2029-2039.
  2. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gyn 2003; 101(6): 1333-44. Go to original source...
  3. Brey RL, Escalante A. Neurological manifestations of antiphospholipid antibody syndrome. Lupus 1998; 7: 67-74. Go to original source... Go to PubMed...
  4. Esplin MS. Management of antiphospholipid syndrome during pregnancy. Clin Obstet Gynecol 2001; 44 (1): 20-28. Go to original source... Go to PubMed...
  5. Feinstein DI. Inhibitors of Blood Coagulation. In: Hematology. Churchill-Livingstone London 2000: 1969-1983.
  6. Galli M, Luciani D, Bertolini G, Barbui T. Anti(beta)2-glycoprotein I, antiprothrombin anti-bodies and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003; 19: (Epub ahead of print). Go to original source... Go to PubMed...
  7. Hanly JG, Antiphospholipid syndrome: an overview. CMAJ 2003; 168 (13): 1675-1682. Go to PubMed...
  8. Khamashta MA. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome. Lupus 1998; 7: 162-165. Go to original source... Go to PubMed...
  9. Lee GR, et al. Wintrobe´s Clinical Hematology. Williams & Wilkins 1998: 1759-1766.
  10. McIntyre JA, Wagenknecht DR, Faulk WP. Antiphospholipid antibodies: discovery, definitions, detection and disease. Prog in Lipid Research May 2003; 42 (3): 176-237. Go to original source... Go to PubMed...
  11. Novotný J, Hyperkoagulační stavy. Lékařské listy 2000; 43: 9-10.
  12. Penka M, et al. Antifosfolipidový syndrom. In: Diseminovaná intravaskulární koagulace. Grada Publishing 2003: 119-133.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.